Cancer News and Research

Latest Cancer News and Research

Women’s Heart Fund announces launch of ‘Community Conversations with the CDI’

The Women's Heart Fund, a philanthropic arm of Hackensack Meridian Health Meridian Health Foundation, has announced that for its newest venture, the organization will sponsor 'Community Conversations with the CDI,' a women-focused, three-year lecture series featuring researchers from Hackensack Meridian Health's Center for Discovery and Innovation.

3 Feb 2020

Investigational HIV vaccine not effective in preventing HIV

The National Institute of Allergy and Infectious Diseases), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine.

3 Feb 2020

HIV antibody therapy improves immune function

A new study published in the journal Nature Medicine in February 2020 reports that the administration of neutralizing antibodies against HIV improve the recipient’s specific T cell responses against the virus.

3 Feb 2020

Eating meat linked to poorer health

The seesaw continues with respect to the benefits of meat eating. The latest large new study published in February 2020 in the journal JAMA Internal Medicine reveals that eating red and processed meat is associated with a small but significantly higher risk of heart disease and death. Says researcher Norrina Allen, “It's a small difference, but it's worth trying to reduce red meat and processed meat like pepperoni, bologna and deli meats.”

3 Feb 2020

Novel approach may offer a more effective way to eradicate colorectal cancer cells

A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a team of researchers based in South Korea.

3 Feb 2020

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.

3 Feb 2020

Arterial stiffness accelerates as women transition through menopause

A marker for heart disease risk considerably worsens as women transition through menopause, according to a new analysis from the largest and longest running study of women's health in midlife, the Study of Women's Health Across the Nation.

3 Feb 2020

Comparing DNA-repair gene mutations in African American and Caucasian men with prostate cancer

Pathogenic or likely pathogenic alterations in these 14 DNA repair genes were less likely to be detected in African Americans as compared to Caucasians.

3 Feb 2020

Researchers reveal mutation's role in blood cancers

A genetic mutation that disrupts how DNA sends messages to the rest of a cell has been linked to a large number of blood cancers.

3 Feb 2020

As VA tests keto diet to help diabetic patients, skeptics raise red flags

A partnership between the Department of Veterans Affairs and Silicon Valley startup Virta Health Corp. is focusing attention on the company's claim that it provides treatment "clinically-proven to safely and sustainably reverse type 2 diabetes" without medication or surgery.

3 Feb 2020

Fermented soy products may help you live longer

A new study has shown that products made of fermented soy such as miso and soy sauce can help individuals live longer. The study titled, “Association of soy and fermented soy product intake with total and cause specific mortality: prospective cohort study,” was published in the latest issue of the journal British Medical Journal.

2 Feb 2020

Discovery about how cancer cells hide from the immune system could improve treatments

Researchers have shed light on the mechanism through which cancer cells become camouflaged to escape immune system detection and attack.

31 Jan 2020

Choice of anesthetic for breast tumor resection may influence cancer outcomes

A study led has added to the evidence that the type of anesthetic administered to cancer patients during tumor surgical resection may affect cancer outcomes.

31 Jan 2020

Research opens the door to healthier white bread

Group identifies the parts of the wheat genome that control fiber content of white flour – raises hope that products will be in supermarkets within five years.

31 Jan 2020

Regenerative biology could be used to restore mucus production, shows study

Mucus is a protective, slimy secretion produced by goblet cells and which lines organs of the respiratory, digestive, and reproductive systems. Slime production is essential to health, and an imbalance can be life-threatening.

31 Jan 2020

New combination treatment could help fight advanced melanoma

A study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.

31 Jan 2020

Choice of anesthesia may change metastatic process of breast cancer

A new study led by Stony Brook University Cancer Center researchers to be published in Nature Communications suggests that the choice of anesthesia may change the metastatic process of breast cancer by affecting the cytokine and microenvironment.

31 Jan 2020

5 things to know about Trump’s Medicaid block grant plan

The Trump administration unveiled a plan Thursday that would dramatically revamp Medicaid by allowing states to opt out of part of the current federal funding program and instead seek a fixed payment each year in exchange for gaining unprecedented flexibility over the program.

31 Jan 2020

A new study reveals the secrets of mucus production that could be applied to cancer biology

The cells that produce mucus are known to be involved in serious health conditions such as asthma, chronic obstructive pulmonary disease, and even cancer.

31 Jan 2020

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

A discovery by University of North Carolina Lineberger Comprehensive Cancer Center researchers could allow scientists to fine-tune genetically engineered immune cells to heighten their killing power against tumors or to decrease their activity level in the case of severe side effects.

31 Jan 2020